Translational research bridges the gap between basic science and clinical application. It transforms scientific discoveries made in the laboratory—such as identifying a molecule or a biological mechanism—into practical tools for diagnosis, treatment, or disease prevention, including for ocular cancers. Its goal is to accelerate the transition “from bench to bedside.”

It relies on close collaboration between researchers, clinicians, biologists, and biostatisticians. For example, results obtained from cell or animal models may lead to the development of new targeted therapies, later tested in clinical trials.

In France, translational research is governed by several regulations, including the French Research Code and ethical rules related to animal and human experimentation. When it involves patients or personal data, it may also fall under the Public Health Code.

Preclinical studies (in laboratory or animal models) follow different regulatory frameworks, usually under basic science or fundamental research.